Life Scientist > Biotechnology

GTG expands testing services

06 May, 2003 by Melissa Trudinger

Genetic Technologies (ASX: GTG) has expanded the range of testing services it can offer through the acquisition of animal testing service Genetic Science Services (GSS).


Four legs good

05 May, 2003 by Melissa Trudinger

It doesn't attract the limelight, but Australia's vet biotech sector is making strides, reports Melissa Trudinger


Plenty of scope for new gene discovery

05 May, 2003 by Melissa Trudinger

What does a scientist do when he has a really interesting gene with blockbuster potential, but no clue about its function?


CSIRO reeling after wheat virus outbreak

02 May, 2003 by Melissa Trudinger

It's a nightmare scenario -- scientists forced to destroy months, even years of their labour to combat an outbreak of a virus never seen in Australia. And it has just happened at CSIRO Plant Industry, where thousands of plants have recently been destroyed to combat the wheat streak mosaic virus (WSMV), a cereal plant pathogen that has never before been identified in Australia.


GM pioneer points to thaw in public opposition

02 May, 2003 by Graeme O'Neill

There are signs that, even in the UK and Europe, consumer and political attitudes towards GM crops and foods are thawing, according to the scientist who has led the global campaign for GM agriculture, Prof Channapatna S Prakash.


Australian consumers don't mind GM: survey

02 May, 2003 by Graeme O'Neill

A new survey suggests the great 'Frankenfood' scare could be over in Australia before it has even begun.


Back GM or see our agriculture markets wilt, conference told

02 May, 2003 by Melissa Trudinger

Australia runs the risk of being left behind if it does not adopt the production of GM crops, according to two recent reports presented at this week's Ag-Biotech Forum in Melbourne.


Ambri tightens its belt, looks for cash

01 May, 2003 by Pete Young

Medical diagnostics company Ambri is striving to tap fresh funding sources while engaging in further staff and cost cutbacks to stretch dwindling cash reserves.


Regulatory framework questioned in Pan fiasco

29 April, 2003 by Jeremy Torr

Recent revelations about Pan Pharmaceuticals and Curacel International have thrown the efficacy of Australia's regulatory system into question, with potentially thousands of product lines facing recall and criminal charges being filed.


CSIRO Animal Health asked to join SARS fight

24 April, 2003 by Melissa Trudinger

United Nations health authorities have asked CSIRO's Australian Animal Health Laboratory (AAHL) to join in the global effort to combat the SARS virus.


Biota set to research neo-epidemics

24 April, 2003 by Jeremy Torr

With SARS ravaging Asia and avian flu decimating Dutch poultry farms, antiviral company Biota is to ramp up activities within the both the treatment and diagnostic fields.


GM virus puts mice off sex

23 April, 2003 by Jeremy Torr

Australia's first GM mammal virus is poised to slash millions of dollars off grain spoilage figures, if medium-scale mouse-limitation trials go according to plan


Radiation technique shows good results in weight reduction trials

22 April, 2003 by Jeremy Torr

Innovative RF radiation techniques have resulted in positive weight reduction results, according to a recent University of Adelaide study.


Prana sets sights on Alzheimer's diagnostic

17 April, 2003 by Jeremy Torr

Possible links between the pathology of the eye and the brain have been identified by Prana consultants working on Alzheimer's patients.


New targets ID'd in hunt for clotting reduction drugs

16 April, 2003 by Melissa Trudinger

Monash University scientists have identified potential new targets for the development of drugs to reduce blood clotting in patients at risk of heart attack or stroke.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd